Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report.

Elisabetta BussalinoAndrea De MariaRodolfo RussoErnesto Paoletti

Published in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2020)

The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2-infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy.

Keyphrases

sars cov
respiratory syndrome coronavirus
electronic health record
machine learning
big data
mesenchymal stem cells
acute respiratory distress syndrome
extracorporeal membrane oxygenation